Nuvectis Pharma Stock Forecast

Buy or Hold candidate since Jun 10, 2026 Gain 85.65%

The Nuvectis Pharma, Inc. stock price gained 2.90% on the last trading day (Friday, 17th Jul 2026), rising from $18.60 to $19.14. During the last trading day the stock fluctuated 4.60% from a day low at $18.37 to a day high of $19.21. The price has been going up and down for this period, and there has been a -2.2% loss for the last 2 weeks. Volume fell on the last day by -11 thousand shares and in total, 331 thousand shares were bought and sold for approximately $6.33 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 77.09% during the next 3 months and, with a 90% probability hold a price between $27.41 and $55.69 at the end of this 3-month period.

NVCT Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Monday, June 29, 2026, and so far it has fallen -32.91%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). The Nuvectis Pharma, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $18.77 and $15.90. A breakdown below any of these levels will issue sell signals. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Nuvectis Pharma, Inc. stock

Nuvectis Pharma, Inc. finds support from accumulated volume at $18.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.85 between high and low, or 4.60%. For the last week, the stock has had daily average volatility of 6.07%.

Our recommended stop-loss: $18.00 (-5.96%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 13 days ago.)

Trading Expectations (NVCT) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Nuvectis Pharma, Inc. to open at $18.91, and during the day (based on 14 day Average True Range), to move between $18.28 and $20.00, which gives a possible trading interval of +/-$1.72 (+/-9.43%) up or down from last closing price. If Nuvectis Pharma, Inc. takes out the full calculated possible swing range there will be an estimated 9.43% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $19.52 (1.99%) than the support at $18.60 (2.82%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Nuvectis Pharma, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Nuvectis Pharma, Inc. stock to perform well in the short-term.

Current score: 3.707 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $18.91 ( 1.23%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk